These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 11470009)
1. Clinical trials report. When can treatment of hypertension be stopped? Weber MA Curr Hypertens Rep; 2001 Aug; 3(4):279-80. PubMed ID: 11470009 [No Abstract] [Full Text] [Related]
2. [The lower, the better: is that true in drug therapy for patients with hypertension?]. Kuwajima I Nihon Rinsho; 2006 Aug; 64 Suppl 6():259-63. PubMed ID: 16983768 [No Abstract] [Full Text] [Related]
4. HOPE-3, SPRINT, VALUE and a meta-analysis of trials in patients with diabetes support treatment of hypertension to a target below 140 mmHg. Kjeldsen SE; Hedner T; Narkiewicz K Blood Press; 2016 Jun; 25(3):131-2. PubMed ID: 27160151 [No Abstract] [Full Text] [Related]
5. Influencing the natural history of hypertension: is it the blood pressure achieved, the drug, or the drug dose? Hollenberg NK J Hypertens; 2008 Aug; 26(8):1527-32. PubMed ID: 18622224 [No Abstract] [Full Text] [Related]
6. Hypertension drug trials: past, present, and future. Sever PS; Poulter NR J Hum Hypertens; 2000; 14(10-11):729-38. PubMed ID: 11095163 [No Abstract] [Full Text] [Related]
7. Workshop II--Hypertension trials and meta-analyses: is there any value for further studies? Grimm RH; Black H Am J Med; 1991 Feb; 90(2A):24S-25S. PubMed ID: 1825263 [No Abstract] [Full Text] [Related]
8. Isolated systolic hypertension in the elderly. Staessen J; Amery A; Fagard R J Hypertens; 1990 May; 8(5):393-405. PubMed ID: 2163412 [No Abstract] [Full Text] [Related]
9. Can large-scale trials or meta-analyses demonstrate blood pressure--independent effect of angiotensin receptor blockers? Minami J; Ishimitsu T; Matsuoka H Hypertension; 2007 Oct; 50(4):e73; author reply e74. PubMed ID: 17724273 [No Abstract] [Full Text] [Related]
10. Targeting systolic blood pressure: the key to controlling combined systolic/diastolic hypertension. Waeber B; Mourad JJ Am J Hypertens; 2006 Sep; 19(9):985-6. PubMed ID: 16942945 [No Abstract] [Full Text] [Related]
11. [Current views on the treatment of borderline and mild hypertension]. Czarniecki W Pol Arch Med Wewn; 1988; 80(2-3):156-61. PubMed ID: 3078206 [No Abstract] [Full Text] [Related]
12. Is it time for a new approach to the initial treatment of hypertension? Moser M Arch Intern Med; 2001 May; 161(9):1140-4. PubMed ID: 11343437 [No Abstract] [Full Text] [Related]
13. [Study of the effectiveness of the clofeline treatment based on the results of its single-dose administration]. Orlov VM; Kolesova MA; Sivkov SI; Panchenkova LA Sov Med; 1991; (2):56-9. PubMed ID: 2057844 [No Abstract] [Full Text] [Related]
14. Potential improvements in antihypertensive drug treatment. Birkenhäger WH; de Leeuw PW Neth J Med; 1990 Aug; 37(1-2):49-52. PubMed ID: 2145520 [No Abstract] [Full Text] [Related]
15. Control of blood pressure after stroke. Bath PM; Sprigg N Hypertension; 2006 Aug; 48(2):203-4. PubMed ID: 16785329 [No Abstract] [Full Text] [Related]
16. How many antihypertensives do patients need to achieve a target blood pressure? Marshall T J Hum Hypertens; 2005 Apr; 19(4):317-9. PubMed ID: 15660116 [No Abstract] [Full Text] [Related]
17. Blood pressure management in the wake of SPRINT. Filippone EJ; Foy AJ Cleve Clin J Med; 2016 Mar; 83(3):196-8. PubMed ID: 26974990 [No Abstract] [Full Text] [Related]